US 10858432
Antibodies specific to glycosylated PD-1 and methods of use thereof
granted A61KA61K39/395A61K47/6849
Quick answer
US patent 10858432 (Antibodies specific to glycosylated PD-1 and methods of use thereof) held by The Board of Regents of the University of Texas System expires Mon Dec 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Dec 08 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61K, A61K39/395, A61K47/6849, A61K9/0019, A61P